Curaleaf Holdings (CURLF) Change in Accured Expenses (2019 - 2024)

Curaleaf Holdings (CURLF) posted quarterly Change in Accured Expenses of -$178.1 million for Q4 2024, down 1047.84% year-on-year from $18.8 million in Q1 2024, and down 514.81% on a QoQ basis from $42.9 million in Q3 2024.

Curaleaf Holdings (CURLF) Change in Accured Expenses (2019 - 2024) Analysis & Trends

Curaleaf Holdings (CURLF) has reported Change in Accured Expenses for 6 consecutive years, with -$178.1 million the latest figure, recorded in Q4 2024.

  • Quarterly Change in Accured Expenses fell 1047.84% year-over-year to -$178.1 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$157.1 million (down 481.58% YoY) and the FY2025 annual result came in at $147.9 million, up 24.91% from the prior year.
  • Change in Accured Expenses retreated to -$178.1 million in Q4 2024 per CURLF's latest filing, from $42.9 million in the prior quarter.
  • Over the last five years, Change in Accured Expenses for CURLF reached as high as $60.7 million in Q4 2021 and fell as low as -$178.1 million in Q4 2024.
  • A 5-year average of -$1.3 million and a median of -$167500.0 in 2021 frame the typical range for Change in Accured Expenses.
  • Annual changes were most pronounced in 2021 — Change in Accured Expenses soared 3430.68% — and 2022, when it tumbled 6757.89%.
  • Year by year, Change in Accured Expenses stood at -$1.8 million in 2020, then surged by 3430.68% to $60.7 million in 2021, then dropped by 0.49% to $60.4 million in 2022, then plunged by 125.7% to -$15.5 million in 2023, then tumbled by 1047.84% to -$178.1 million in 2024.
  • According to Business Quant data, Change in Accured Expenses over the past three periods registered -$178.1 million, $42.9 million, and -$15.5 million for Q4 2024, Q3 2024, and Q4 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -144.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -234.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -12.70 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -14.30 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Curaleaf Holdings 7.13 Bn 7.13 Bn 157.29 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 -178.11 Mn
Dec 31, 2024 -178.11 Mn
Sep 30, 2024 42.94 Mn
Sep 30, 2024 42.94 Mn
Dec 31, 2023 -15.52 Mn
Dec 31, 2023 -15.52 Mn
Sep 30, 2023 -6.46 Mn
Sep 30, 2023 -6.46 Mn
Dec 31, 2022 60.39 Mn
Dec 31, 2022 60.39 Mn
Sep 30, 2022 2.77 Mn
Sep 30, 2022 2.77 Mn
Jun 30, 2022 -6.33 Mn
Jun 30, 2022 -6.33 Mn
Mar 31, 2022 -430,000.00
Mar 31, 2022 -430,000.00
Dec 31, 2021 60.69 Mn
Dec 31, 2021 60.69 Mn
Sep 30, 2021 23.27 Mn
Sep 30, 2021 23.27 Mn